Use of ribavirin monitoring to predict significant anaemia in patients being treated for Hepatitis C

被引:0
|
作者
Barnabas, Ashley [1 ]
Wang, Bo [1 ]
Michur, Halina [1 ]
Knighton, Sarah [1 ]
Verma, Suman [1 ]
Morgan, Phillip [1 ]
Suddle, Abid [1 ]
Carey, Ivana [1 ]
Tredger, J. Michael [1 ]
Agarwal, Kosh [1 ]
机构
[1] Kings Coll Hosp London, Inst Liver Studies, Kings Coll London, London Sch Med, London SE5 8RX, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1975
引用
收藏
页码:1163A / 1164A
页数:2
相关论文
共 50 条
  • [1] Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin
    Sherman, Morris
    Cohen, Lawrence
    Cooper, Mary Anne
    Elkashab, Magdy
    Feinman, Victor
    Fletcher, David
    Girgrah, Nigel
    Heathcote, Jenny
    Levstik, Mark
    McNaull, William B.
    Wong, David
    Wong, Florence
    Yim, Colina
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (07) : 479 - 485
  • [2] Ribavirin monitoring in chronic hepatitis C therapy: anaemia versus efficacy
    Brochot, Etienne
    Castelain, Sandrine
    Duverlie, Gilles
    Capron, Dominique
    Nguyen-Khac, Eric
    Francois, Catherine
    [J]. ANTIVIRAL THERAPY, 2010, 15 (05) : 687 - 695
  • [3] Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents
    Molina-Cuadrado, Emilio
    Mateo-Carrrasco, Hector
    Collado, Antonio
    Martin, Marta Casado
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2018, 25 (03) : 132 - 137
  • [4] Risk factors of anaemia in chronic hepatitis C patients treated by interferon alfa and ribavirin combination therapy
    Akbar, Femmy
    Albar, Zulyasri
    Muthalib, Abdul
    Lesmana, Laurentius A.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A27 - A27
  • [5] Hemolysis in patients being treated with combination Intron A ribavirin for chronic hepatitis C (HCV) infection
    Box, TD
    Boschert, ME
    Thomason, IR
    Bowers, JH
    Hutson, WR
    Christiansen, JE
    Gish, RG
    Brooks, L
    [J]. HEPATOLOGY, 1998, 28 (04) : 574A - 574A
  • [6] Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin
    Paradis, Valerie
    Asselah, Tarik
    Dargere, Delphine
    Ripault, Marie-Pierre
    Martinot, Michele
    Boyer, Nathalie
    Valla, Dominique
    Marcellin, Patrick
    Bedossa, Pierre
    [J]. GASTROENTEROLOGY, 2006, 130 (07) : 2189 - 2197
  • [7] Thyroid Disorders in Hepatitis C Patients Treated or Not With α-Interferon and Ribavirin
    Xavier Santos, Sandra Regina
    Ferreira, Marcelo Simao
    Borges, Aercio Sebastiao
    Costa Pinto, Rogerio de Melo
    Pereira Mendonca Fernandes, Maria Luiza
    Jorge, Paulo Tannus
    [J]. ENDOCRINOLOGIST, 2010, 20 (03): : 122 - 124
  • [8] Normal erythropoietin response in chronic hepatitis C patients with ribavirin-induced anaemia
    Mangoni, ED
    Marrone, A
    Saviano, D
    Del Vecchio, C
    Utili, R
    Ruggiero, G
    [J]. ANTIVIRAL THERAPY, 2003, 8 (01) : 57 - 63
  • [9] Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
    Bani-Sadr, F.
    Goderel, I.
    Penalba, C.
    Billaud, E.
    Doll, J.
    Welker, Y.
    Cacoub, P.
    Pol, S.
    Perronne, C.
    Carrat, F.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2007, 14 (09) : 639 - 644
  • [10] Outcome of Retinopathy in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin
    Nilesh Mehta
    Uma K. Murthy
    Vivek Kaul
    Samuel Alpert
    Gerald Abruzzese
    Charles Teitelbaum
    [J]. Digestive Diseases and Sciences, 2010, 55 : 452 - 457